MTSI · MACOM Technology Solutions Holdings, Inc.

Current Thesis

MACOM’s optical-component growth story now has a commercial 3.2-terabit product extension; recovery above the August earnings close would confirm renewed price support, while loss of the August closing low would invalidate that recovery thesis. The financial anchor remains management’s 2026-08-06 fiscal fourth-quarter revenue guidance of $415–425 million, following third-quarter revenue of $342.2 million.

The material changes since September 5 are company-specific. MACOM announced its 3.2-terabit-per-second chipset on 2026-09-17 and said the products were available. BMO Capital upgraded the shares to Outperform on 2026-09-18 while retaining its $335 analyst target. These are a product announcement and an analyst reassessment; neither establishes incremental customer orders. MACOM announcement, BMO action reported by Benzinga.

The lifecycle assessment is an inference: the narrative is maturing — the 2026-09-17 product extension and 2026-09-18 upgrade weaken the earlier saturation argument, but the September 18 close of $275.86 remains below the August 27 close of $277.15. Fresh coverage has arrived without a confirmed range breakout. The case plays out with a weekly close above $301.64, the 2026-08-06 earnings-session close, before a weekly close below $257.43, the 2026-08-24 close.

Bullish and bearish views on MACOM Technology Solutions Holdings, Inc.

The model's bull view on MACOM Technology Solutions Holdings, Inc. (MTSI), in brief: Orders exceeded current shipments. On the 2026-08-06 earnings call, MACOM reported a book-to-bill ratio of 1.6:1 and Data Center revenue of $137.6 million, approximately 40% above the preceding quarter. Book-to-bill compares orders with revenue; these reported figures support… The bear view: The earnings-session close remains unrecovered. Both cases follow in full.

Bull Case

• Orders exceeded current shipments. On the 2026-08-06 earnings call, MACOM reported a book-to-bill ratio of 1.6:1 and Data Center revenue of $137.6 million, approximately 40% above the preceding quarter. Book-to-bill compares orders with revenue; these reported figures support the demand argument without proving that every order will convert.
• The revenue test is explicit. MACOM’s 2026-08-06 fourth-quarter guidance called for $415–425 million of revenue and an adjusted gross margin of 60–61%. Delivery of those figures would support the operating thesis; revenue below the guided range would contradict it.
• The product roadmap advanced. MACOM’s 2026-09-17 announcement combined receive-side amplifiers and photodiodes with transmit drivers in its 3.2-terabit chipset. The release establishes product availability but gives no associated revenue figure. Company release.

Bear Case

• The earnings-session close remains unrecovered. The supplied historical record places the 2026-08-06 close at $301.64; the adjusted reference close on 2026-09-18 was $275.86. The latest close therefore has not confirmed recovery of that public earnings reference.
• The broader decline remains substantial. As of 2026-09-18, the supplied adjusted series records a three-month price decline of 30.4% and a close 32.7% below its $409.68 trailing-year high. Those measurements limit the case for an established upward trend.
• An upgrade is not an order. BMO’s 2026-09-18 move to Outperform retained its $335 target, according to Benzinga. The rating change documents improved analyst opinion; it does not measure customer demand or institutional inflows. Analyst action.

Setup & Price Structure

Measured momentum has improved since the previous review: the 14-period relative strength index (RSI) was 54.3 on 2026-09-18, compared with 25.9 on 2026-09-04 in the supplied adjusted record. These observations establish a stronger momentum reading, but the sample is too small to establish durable accumulation.

The 2026-08-24 close of $257.43 is the downside reference; the 2026-08-27 close of $277.15 is the nearby recovery reference. A weekly close above $301.64 would complete the defined recovery case. A weekly close below $257.43 would invalidate it. These thresholds describe the market structure, not execution levels.

Positioning evidence remains limited. The September 18 BMO upgrade is observable coverage activity, and MACOM has confirmed its September exhibition appearance. Neither establishes retail crowding. Current moving-average values, short-interest measurements and verified recent insider transactions are missing, so no positioning conclusion rests on them.

Catalyst Calendar (next 30 days)

• 2026-09-21 through 2026-09-23 — MACOM at the European Conference on Optical Communication (ECOC), Málaga. MACOM confirmed its attendance and demonstration program on 2026-09-15. The event provides a dated check on the product roadmap; demonstration activity alone does not resolve revenue conversion. MACOM event announcement.
• ~2026-11-05, estimated — fiscal fourth-quarter and full-year results. This later event is included because it tests the $415–425 million revenue guidance issued on 2026-08-06. MarketBeat lists November 5 as estimated; company confirmation has not been established. Estimated earnings calendar.

What Would Change Our Mind

Loss of the August closing floor would break the recovery thesis: a weekly close below $257.43 would put the shares beneath the 2026-08-24 reference close. Independently, reported fourth-quarter revenue below $415 million would fail the low end of management’s 2026-08-06 guidance and weaken the order-conversion argument.

The stronger interpretation requires a weekly close above the $301.64 earnings-session reference from 2026-08-06. The subsequent results must distinguish product availability from realized revenue. ECOC ending on 2026-09-23 without disclosed customer orders would leave that commercial question unresolved; absence of an announcement would not establish absence of demand.

Correlation Notes

This remains a single-name optical-components setup. MACOM’s 2026-09-15 exhibition announcement connects its products to artificial-intelligence infrastructure, cloud data centers and telecommunications, establishing economic exposure to those markets. It does not establish a measured share-price correlation with optical peers. MACOM product program.

The dated price observations through 2026-09-18 are insufficient to determine whether participation across the optical group has broadened. The recovery case therefore depends on MACOM’s own published close levels and revenue guidance, rather than an assumed sector advance.